Related Experiment Video
Updated: Apr 16, 2026

14:45
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
15.6K
Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smears
Siddharth Singi1, Shenghuan Sun2, Zhanghan Yin3,4
1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. singis@mskcc.org.
Communications Medicine
|April 14, 2026
Summary
A new computational framework, CAREMIL, accurately diagnoses hematologic malignancies from blood smears by analyzing cell aggregation and morphology. This approach provides reliable, interpretable slide-level predictions for conditions like acute myeloid leukemia.
Area of Science:
- Computational pathology
- Hematologic diagnostics
- Machine learning in medicine
Background:
- Accurate diagnosis of hematologic malignancies from peripheral blood smears (PBSs) requires integrating cellular morphology and composition.
- Current computational methods often focus on single-cell classification, lacking holistic, slide-level diagnostic capabilities.
Purpose of the Study:
- To develop and validate a novel computational framework for accurate, interpretable, slide-level diagnosis of hematologic malignancies.
- To integrate high-performance cell-based feature extraction with a weakly supervised, attention-based multiple instance learning (MIL) model.
Main Methods:
- A framework combining DeepHeme (cell-based encoder) and CAREMIL (weakly supervised, attention-based MIL) was developed.
- Evaluated performance against leading image encoders and MIL architectures, including out-of-domain models.
- CAREMIL demonstrated robust cell aggregation and attention mechanisms for slide-level analysis.
Main Results:
- CAREMIL with DeepHeme achieved high diagnostic accuracy for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and hairy cell leukemia (HCL) (AUROCs: 0.999, 0.891, 0.945).
- The model successfully identified AML even with minimal circulating blasts and provided interpretable insights via attention values highlighting diagnostically relevant cells.
- The framework showed resilience to individual cell misclassifications and did not require cell-level supervision.
Conclusions:
- CAREMIL is an effective and interpretable MIL framework for hematologic slide diagnosis.
- The framework is extendable to other specimen types like bone marrow aspirates and cytology.
- Supports a move towards quantitative, morphology-informed hematologic diagnostics.

